Property:Age groups specification
This is a property of type Text.
A
Afonseca et al. (2013): Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial +
Mean value = 56.5 years; range: 29-76 years +
Akiba et al. (2018): Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial +
Mean (SD): 68 (9) +
Ansari et al. (2016): Efficacy of Ginger in Control of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients Receiving Doxorubicin- Based Chemotherapy +
Mean (range) in years: 48.6 (25-79) +
Median age: 69 (24-79) +
Arbabi-kalati et al. (2012): Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A double-blind randomized clinical trial +
Intervention arm: MW (SD): 51.5 (3.3), Range: 18-70
Placebo arm: MW (SD): 47.2 (3.5), Range: 18-79 +
Argyriou et al. (2006): A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results +
Age Mean (SD): 56.7 (13.7) +
Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation +
Age Mean (SD) = 57.0 (9.9) (ITT population) +
Arslan et al. (2015): Oral Intake of Ginger for Chemotherapy-Induced Nausea and Vomiting Among Women With Breast Cancer +
Mean: 48.5 years +
Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients +
NI +
Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer +
Intervention arm: median (range): 72.0 (50.0-85.0)
Placebo arm: median (range): 70.0 (52.0-82.0) +
Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis +
Mean (SD) = 30.72 (8.41) years +
B
Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients +
Mean (SD) in years per arm:
- intervention: 62.9 (10.0)
- placebo: 62.3 (9.5) +
Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients +
Mean (SD) in years per arm:
- intervention: 62.9 (10.0)
- placebo: 62.3 (9.5) +
Bairati et al. (2006): Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients +
Mean (SD) in years per arm:
- intervention: 62.9 (10.0)
- placebo: 62.3 (9.5) +
Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors +
18-49 years: 34.4%; ≥50 years: 65.6% +
Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 +
Age (years): <50 = 50%; ≥50 = 50% +
Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators +
Intervention arm: median (range): 68 (45-87)
Placebo arm: median (range): 70 (47-92) +
Bossi et al. (2017): A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin +
Mean (SD) intervention vs. placebo: 58.8 (10.4) vs. 59.5 (10.0) years +
Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer +
MW (SD): 63 (15) +
Braik et al. (2014): Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy +
Age in years: mean (SD) = 54.1 (10.41); range: 25-78 +